Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focus |
cardiovascular diseases
autoimmune diseases development of therapies for serious diseases orphan diseases |
| gptkbp:foundedYear |
2004
|
| gptkbp:headquartersLocation |
gptkb:Hayward,_California
|
| https://www.w3.org/2000/01/rdf-schema#label |
Anthera Pharmaceuticals
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
gptkb:Sollpura
gptkb:blisibimod |
| gptkbp:status |
defunct
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:ANTH
|
| gptkbp:website |
http://www.anthera.com
|
| gptkbp:bfsParent |
gptkb:Sofinnova_Investments
|
| gptkbp:bfsLayer |
6
|